Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
GSK, mRNA
British drugmaker GSK moves mRNA flu vaccine to late-stage trials
(Reuters) -British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine programme using the messenger RNA (mRNA) technology, and said it would now progress to late-stage clinical development.
GSK Says mRNA Flu Shot Shows Promise in Boost for Pipeline
GSK Plc’s experimental mRNA flu vaccine showed a positive immune response against two key types of flu viruses in a mid-stage trial, keeping the drugmaker in the race to bring the technology to seasonal influenza shots.
GSK's mRNA flu vaccine finally overcomes tricky B strains in phase 2 trial
After an initial defeat against the biggest barrier to mRNA flu vaccines—namely, B strains of influenza—GSK has returned with a reformulated candidate that has
GSK, CureVac mRNA flu shot reaches late-stage studies
GSK
(NYSE:
GSK
) on Thursday announced its decision to advance its messenger-RNA-based
flu vaccine
candidate developed with CureVac (NASDAQ:CVAC) into late-stage development following a positive Phase 2 readout. The British drugmaker said that the
vaccine
...
GSK’s mRNA seasonal flu vaccine shows promise in younger and older adults
GSK has shared positive headline results for its mRNA seasonal influenza vaccine and outlined that it will now progress the programme into late-stage clinical development. The phase 2 NCT06431607 study has been evaluating different dose levels of a modified,
GSK’s mRNA Flu Vaccine Candidate Moves to Phase III After Positive Phase II Results
GSK has reported positive results from its phase II trial for an mRNA seasonal influenza vaccine candidate, showing strong immune responses again
British drugmaker GSK moves mRNA flu vaccine to late-stage trials
British drugmaker
GSK
(
GSK
.L), opens new tab announced on Thursday positive results from a mid-stage trial of its seasonal
influenza
vaccine
programme using the messenger RNA (mRNA) technology ...
FDA approves an at-home flu vaccine
FDA approves ‘FluMist,' says no healthcare provider needed
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the regulator said.
FDA approves first nasal spray flu vaccine for use at home
The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a prescription will be able to order online starting next year. Health experts say the convenience of the spray — FluMist — could lead to increased flu vaccination rates.
Nasal flu vaccine is approved for at-home use
The FDA authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.
Morningstar
10d
GSK's mRNA Flu Vaccine Advances to Late-Stage Clinical Development After Positive Trial Results
GSK
said its would move its seasonal mRNA
flu vaccine
to late-stage clinical development after positive Phase 2 trial results. The British pharma giant said Thursday that the trial studied a range ...
Health Affairs
2d
How Policy Makers Can Act Now To Prevent An Avian Influenza Pandemic
It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
On running again in 2028
Alabama mass shooting
Daylight saving time
Ga. suspect's mom indicted
Actress Crosby dies at 90
San Francisco homelessness
To skip Al Smith dinner
Donlon's homes searched
CA firefighter held for arson
No. 1 at box office again
ISR raids Al Jazeera office
House repeals emission rules
Biden hosts 'Quad' summit
CAH sues for trespassing
Suns broadcaster dies
Former WA governor dies
Iran coal mine blast
Released after guilty plea
FDA approves flu vaccine
Drug price challenge revived
Pandas leaving for China
TN abortion law blocked
Boeing defense chief exits
SC 1st execution in 13 years
CA bill to protect kids online
Sesame Place suit verdict
Beirut strike death toll
J&J unit files for bankruptcy
Hezbollah rockets hit Israel
Feedback